There are times when having an in-house partnering expert is not practical, even for something important: A deal diligence assessment may come up suddenly and require rapid turnaround. The management of a strategic alliance may not justify a full time hire. The integration of two organizations after an M&A deal may be intense but is finite in duration. A dispute may arise with a partner that is difficult to navigate.
In these cases, individuals within an organization take on this important work in addition to their full time jobs. I founded LBBAL™ Alianza to make best-in-class partnering expertise accessible in these instances to support and supplement in-house efforts, and to provide a venue for mentoring and professional development for those who wish to pursue a career in biotech and pharma partnering.
With over 20 years of professional experience, LBBAL™ Alianza provides tailored advice, assessing opportunities and risks at every stage of work, from scientific research to commercialization. Our efficient and capital-conservative approach ensures success in our clients’ projects.
Prior to launching LBBAL™ Alianza, Dr. Rosoff was a partnering executive with roles of increasing seniority at Genentech, Gilead, Kite and Exelixis. Over the course of over two decades, she had the opportunity to lead and participate in a wide diversity of deals, negotiations, diligence exercises, alliances, technology transfers, M&A integrations, dispute resolution negotiations, amendments and terminations–at all stages of the drug development and commercialization lifecycle and in multiple therapeutic areas.
Dr. Rosoff earned a doctorate in Pharmacology from the University of Washington, where she was an HHMI pre-doctoral fellow in the laboratory of Randall T. Moon. She conducted her postdoctoral work at Stanford, studying Wnt signal transduction and cell adhesion under the guidance of James Nelson. Dr. Rosoff additionally gained valuable applied biotechnology experience at Ingenuity Systems (now part of Qiagen), Caliper Life Sciences and Lynx Therapeutics (now part of Illumina) in operational, program management and business development roles.
Our team is composed of pharma and biotechnology professionals with deep and complementary professional experience in their areas of expertise. LBBALTM Alianza’s provides their consultants with the opportunity to share their incredible expertise with others in an environment that supports work-life balance and continuing professional development, including the hiring of consultants by our client if this is the best path forward for everyone involved.
Holds a PhD in Chemical Biology and performed research in academia (Scripps and UCSF) and industry focusing on protein glycosylation and the design of protein-drug conjugates and bi-specific molecules targeting T-cell engagement. Desiree worked at Amunix and Nura as a Senior Scientist responsible for research programs, IND package generation and CRO management. She then transitioned to the management of partnerships at Atomwise, Exelixis and SandboxAQ. In these roles, Desiree has managed partnerships where artificial intelligence is a key contributor to the collaboration workflow, and has gained substantial expertise in asset divestiture, asset integration and technology transfer.
With LBBALTM Alianza, Desiree is available to deliver consulting services related to deal diligence, database implementation, meeting facilitation and documentation, contractual obligation and milestone tracking, joint budget management, and custom technology transfer, asset transfer and M&A integration assignments.
Is a seasoned biologist with 15 years of experience in research and therapeutics. Trained at renowned institutions like the Salk Institute, UCSD, and the European Institute of Oncology, Gabriele has a strong publication record in high-impact journals such as Nature, Nature Cell Biology, and Nature Reviews Cancer.
Gabriele led drug discovery programs from early-stage research to IND applications and in addition provided strategic input across to research, commercial planning, and business development. Gabriele is available to advise LBBALTM Alianza’s clients regarding deal pitch decks, deal diligence, collaborative R&D work plans designed to achieve critical milestones (e.g., target selection, experimental design, success criteria definition, biomarker identification), clinical plans and CRO and KOL selection.
Possesses thirty years of drug development experience with significant breadth of expertise in driving bespoke assay development/optimizations in diverse therapeutic areas while at Scios/J&J, Roche, Nuvelo, Gilead, AMT, Tizona and Moonwalk. This includes target ID, small molecule/large molecule hit-to-lead ID, potency/IC50, hit-to-lead, HTS, MoA, cytotoxicity, antibody discovery, T cell functional assays, tissue and serum/blood/PBMC biomarker assay development/validation for PK/PD, (MSD ELISA and IHC/ISH), as well as deep molecular biology (RNA, NGS, CRISPR), cell culture and cell transduction knowledge.
Representing LBBALTM Alianza, Ford can provide clients with a best-in-class assessment of the quality and viability of R&D plans and identify risks and opportunities during deal diligence. Ford is also available to support clients on a fractional basis with technology transfers, asset purchases and M&A technically focused integration activities.
Has more than 30 years’ experience in statistical methodology, management and clinical biostatistics applied to clinical research and drug development, with stints at Janssen/J&J, Actelion, Novartis, Merck-Serono and Serono. Marisa is passionate about providing quantitative support to strategic decision making and has supported drug development for rare and complex diseases in oncology, neurosciences, immunology and PAH. Marisa is the former president of the European Federation of Statisticians in the Pharma Industry (EFSPI) and a current member of the Basler Biometric Society Council.
Marisa is available as an expert arbitration and litigation witness and as an advisor to executive LBBALTM Alianza clients providing quantitative decision making support regarding critical questions relating to study and program design, challenges and opportunities including interactions with regulators, evidence generation, use of RWE, use of digital endpoints & PROs, among others. Additionally, Marisa is available to provide expert consulting services in the areas of due diligence, term sheet & contract review, facilitation of joint data monitoring committees, and custom fractional assignments related to M&A organizational integrations of analytical/biometric functions.
Provides LBBAL Alianza with legal counsel. Krys is a WSGR alum and has evolved into a biotechnology and pharma executive with a unique blend of legal background, business acumen and operational capabilities acquired in roles of increasing seniority at Genentech, Roche, Oric and Lyell.
We would be happy to structure a custom package of recurring consulting services that you can extend on a monthly or quarterly basis, depending on what you need.
Yes, you may email, request a phone call or schedule for time via our scheduling portal anytime. We will respond promptly (weekends and bank holidays excluded).
There are several options: We provide mentoring services which would help you to better understand how to navigate deals and alliances that you might be involved with at your current company. You could join our Alianza Network to participate in small lunch-and-learn sessions focused on sharing best practices and strategies to manage common partnership challenges. If you are seeking a new position, but you are not an expert, there may be opportunities for you to develop skills working for LBBAL™ Alianza in an operational role that would allow you to shadow the experts.
Please contact Monica Rosoff, CEO, directly at monica@lbbalalianza.com to share your experience. Our goal is to tailor our services to your needs and constraints, so prompt feedback is critical to making any necessary adjustments.
Please send your resume and a statement highlighting the expertise that you would like to share with others to expertconsult@lbbalalianza.com.
In very exceptional circumstances, we may opt to discount our services, or to offer an alternative payment arrangement. Please share your particular circumstances in your inquiry and we will advise what might be feasible.
The best way to determine how we can assist you best is to hold a live, non-confidential, complimentary 30 minute consultation. Please submit your inquiry and select a consultation time that works for you.
